. 2023 Feb 10;13:2421. doi: 10.1038/s41598-023-29577-x

Table 2.

Experimental design showing phenotype treatments and their sequential alteration.

	t0 (up to 34 weeks)	t1 (34 weeks)	t2 (38 weeks)	t3 (44 weeks)
Original homogeneous groups	100M	30U/70M	50U/50M	70U/30M
Original homogeneous groups	100U	30M/70U	50M/50U	70M/30U
Original heterogeneous groups: CONTROLS	30U/70M	- - - -- - - - - - - - -- - - - - - - - - -- - - -- - - -- - - -- - - -- - - - →
	50M/50U	- - - -- - - - - - - - -- - - - - - - - - -- - - -- - - -- - - -- - - -- - - - →
	30M/70U	- - - -- - - - - - - - -- - - - - - - - - -- - - -- - - -- - - -- - - -- - - - →

M marked, U unmarked, t0 initial treatments, t1 1st phenotype alteration, t2 2nd phenotype alteration, t3 3rd phenotype alteration.